Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia

Por Profaci, Caterina P., Krolikowski, Kristyn A., Olszewski, Rafal T., Neale, Joseph H.
Publicado em 2011

The effects of healthy aging on the mnemonic benefit of survival processing

Por Stillman, Chelsea M., Coane, Jennifer H., Profaci, Caterina P., Howard, James H., Howard, Darlene V.
Publicado em 2014

Advances in Understanding the Peptide Neurotransmitter NAAG and Appearance of a New Member of the NAAG Neuropeptide Family

Por Neale, Joseph H., Olszewski, Rafal T., Zuo, Daiying, Janczura, Karolina J., Profaci, Caterina P., Lavin, Kaleen M., Madore, John C., Bzdega, Tomasz
Publicado em 2011

Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer’s disease

Por Khan, Usman A, Liu, Li, Provenzano, Frank A, Berman, Diego E, Profaci, Caterina P, Sloan, Richard, Mayeux, Richard, Duff, Karen E, Small, Scott A
Publicado em 2013